EP3157520
APREMILAST FOR THE TREATMENT OF A LIVER DISEASE OR A LIVER FUNCTION ABNORMALITY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.6.2015EP published:
4.9.2019EP application number:
15739070.9
EPO information:
European Patent Register
Max expiry date:
21.6.2035
Title:
APREMILAST FOR THE TREATMENT OF A LIVER DISEASE OR A LIVER FUNCTION ABNORMALITY
Timeline
Today
22.6.2015EP application
4.9.2019EP Publication
Owner
Name:
Celgene CorporationAddress:
86 Morris Avenue, 07901, Summit, NJ, US
Inventor
Name:
HOUGH, DouglasAddress:
Martinsville, NJ, US
Name:
STEVENS, RandallAddress:
Rockport, MA, US
Priority
Number:
201462016013 PDate:
23.6.2014Country:
US
Classification
Categories:
A61K 31/4035, A61P 1/16, A61K 9/20